{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:11:41Z","timestamp":1788941501006,"version":"build-2803163510"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2016,8]]},"abstract":"<jats:p>\n                    Heart failure remains a major public health concern because of its high prevalence, morbidity, mortality, and financial burden. The poor clinical outcomes associated with acute decompensated heart failure, suboptimal efficacy and safety profile of conventional treatment regimens, and unsatisfactory experiences with the newer classes of pharmacologic therapy underlie the interest in the use of extracorporeal isolated ultrafiltration in this setting. In this article, selected mechanistic aspects of ultrafiltration therapy are briefly reviewed followed by a critical overview of the largest trials in this field. I will discuss the clinical relevance of renal dysfunction and decongestion as two commonly used end points of safety and efficacy in the ultrafiltration trials, with emphasis on the emerging pertinent notions that could challenge our conventional thinking. Finally, a number of practical recommendations (\n                    <jats:italic toggle=\"yes\">e.g.<\/jats:italic>\n                    , customization of ultrafiltration rates) are provided for ultrafiltration therapy in the setting of acute decompensated heart failure. Because of a paucity of evidence, universally accepted consensus guidelines cannot yet be generated. As such, when considering ultrafiltration therapy for acute decompensated heart failure, the likely benefits should be carefully balanced against the potential risks for an individual patient. A conceivable implication of the ultrafiltration trials is that collaborative heart failure programs benefiting from nephrology expertise and resources could improve the outcomes and reduce the cost.\n                  <\/jats:p>","DOI":"10.2215\/cjn.13461215","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T22:50:16Z","timestamp":1459464616000},"page":"1463-1471","source":"Crossref","is-referenced-by-count":26,"title":["Ultrafiltration Therapy for Heart Failure: Balancing Likely Benefits against Possible Risks"],"prefix":"10.2215","volume":"11","author":[{"given":"Amir","family":"Kazory","sequence":"first","affiliation":[{"name":"Division of Nephrology, Hypertension, and Renal Transplantation, University of Florida, Gainesville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2016,3,31]]},"reference":[{"key":"B1-20230816","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","article-title":"Framingham Heart Study: Lifetime risk for developing congestive heart failure: The Framingham Heart Study","volume":"106","author":"Lloyd-Jones","year":"2002","journal-title":"Circulation"},{"key":"B2-20230816","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: A policy statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ Heart Fail"},{"key":"B3-20230816","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1001\/jama.2010.533","article-title":"Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure","volume":"303","author":"Hernandez","year":"2010","journal-title":"JAMA"},{"key":"B4-20230816","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMsa0803563","article-title":"Rehospitalizations among patients in the Medicare fee-for-service program","volume":"360","author":"Jencks","year":"2009","journal-title":"N Engl J Med"},{"key":"B5-20230816","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ahj.2010.07.020","article-title":"Generalizability and longitudinal outcomes of a national heart failure clinical registry: Comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries","volume":"160","author":"Kociol","year":"2010","journal-title":"Am Heart J"},{"key":"B6-20230816","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/jama.2011.1474","article-title":"National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008","volume":"306","author":"Chen","year":"2011","journal-title":"JAMA"},{"issue":"Suppl B","key":"B7-20230816","doi-asserted-by":"crossref","first-page":"B13","DOI":"10.1093\/eurheartj\/sui008","article-title":"Reassessing treatment of acute heart failure syndromes: The ADHERE Registry","volume":"7","author":"Gheorghiade","year":"2005","journal-title":"Eur Heart J"},{"key":"B8-20230816","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"key":"B9-20230816","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"B10-20230816","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"Effect of nesiritide in patients with acute decompensated heart failure","volume":"365","author":"O\u2019Connor","year":"2011","journal-title":"N Engl J Med"},{"key":"B11-20230816","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0735-1097(01)01479-6","article-title":"Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure","volume":"38","author":"Marenzi","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"B12-20230816","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/0735-1097(93)90685-T","article-title":"Isolated ultrafiltration in moderate congestive heart failure","volume":"21","author":"Agostoni","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"B13-20230816","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0002-9149(99)80229-X","article-title":"Lung-heart interaction as a substrate for the improvement in exercise capacity after body fluid volume depletion in moderate congestive heart failure","volume":"76","author":"Agostoni","year":"1995","journal-title":"Am J Cardiol"},{"key":"B14-20230816","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/hrt.72.6.534","article-title":"Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention","volume":"72","author":"Guazzi","year":"1994","journal-title":"Br Heart J"},{"key":"B15-20230816","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0002-9343(94)90142-2","article-title":"Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: Failure of furosemide to provide the same result","volume":"96","author":"Agostoni","year":"1994","journal-title":"Am J Med"},{"key":"B16-20230816","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000258552","article-title":"Cardiac efficiency improvement after slow continuous ultrafiltration is assessed by beat-to-beat minimally invasive monitoring in congestive heart failure patients: A preliminary report","volume":"29","author":"Giglioli","year":"2010","journal-title":"Blood Purif"},{"key":"B17-20230816","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1054\/jcaf.2003.28","article-title":"Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients","volume":"9","author":"Jaski","year":"2003","journal-title":"J Card Fail"},{"key":"B18-20230816","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2005.05.099","article-title":"Early ultrafiltration in patients with decompensated heart failure and diuretic resistance","volume":"46","author":"Costanzo","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"B19-20230816","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2215\/CJN.02910313","article-title":"Cardiorenal syndrome: Ultrafiltration therapy for heart failure--trials and tribulations","volume":"8","author":"Kazory","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B20-20230816","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","article-title":"Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure","volume":"49","author":"Costanzo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"B21-20230816","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N Engl J Med"},{"key":"B22-20230816","doi-asserted-by":"crossref","first-page":"378.e1","DOI":"10.1016\/j.cardfail.2013.11.004","article-title":"Continuous ultrafiltration for congestive heart failure: The CUORE trial","volume":"20","author":"Marenzi","year":"2014","journal-title":"J Card Fail"},{"key":"B23-20230816","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jchf.2015.08.005","article-title":"Aquapheresis versus intravenous diuretics and hospitalizations for heart failure","volume":"4","author":"Costanzo","year":"2016","journal-title":"JACC Heart Fail"},{"key":"B24-20230816","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/CIRCHEARTFAILURE.112.000309","article-title":"Ultrafiltration in heart failure with preserved ejection fraction: Comparison with systolic heart failure patients","volume":"6","author":"Jefferies","year":"2013","journal-title":"Circ Heart Fail"},{"key":"B25-20230816","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000342457","article-title":"Reduction in body weight but worsening renal function with late ultrafiltration for treatment of acute decompensated heart failure","volume":"123","author":"Dev","year":"2012","journal-title":"Cardiology"},{"key":"B26-20230816","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1751-7133.2008.00020.x","article-title":"Comparison of ultrafiltration, nesiritide, and usual care in acute decompensated heart failure","volume":"14","author":"Bartone","year":"2008","journal-title":"Congest Heart Fail"},{"key":"B27-20230816","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1751-7133.2011.00231.x","article-title":"Extracorporeal ultrafiltration vs. conventional diuretic therapy in advanced decompensated heart failure","volume":"18","author":"Hanna","year":"2012","journal-title":"Congest Heart Fail"},{"key":"B28-20230816","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cardfail.2007.09.007","article-title":"A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure","volume":"14","author":"Rogers","year":"2008","journal-title":"J Card Fail"},{"key":"B29-20230816","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/eurheartj\/ehi859","article-title":"Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: Results of the prospective outcomes study in heart failure (POSH)","volume":"27","author":"Cowie","year":"2006","journal-title":"Eur Heart J"},{"key":"B30-20230816","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jacc.2005.11.084","article-title":"Renal impairment and outcomes in heart failure: Systematic review and meta-analysis","volume":"47","author":"Smith","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B31-20230816","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejheart.2008.01.011","article-title":"Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance","volume":"10","author":"Metra","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"B32-20230816","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacc.2003.07.031","article-title":"Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure","volume":"43","author":"Forman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B33-20230816","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1161\/CIRCHEARTFAILURE.111.963256","article-title":"Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction","volume":"4","author":"Testani","year":"2011","journal-title":"Circ Heart Fail"},{"key":"B34-20230816","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCULATIONAHA.109.933275","article-title":"Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival","volume":"122","author":"Testani","year":"2010","journal-title":"Circulation"},{"key":"B35-20230816","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.cardfail.2014.09.005","article-title":"Cardiorenal interactions in acute decompensated heart failure: Contemporary concepts facing emerging controversies","volume":"20","author":"Kazory","year":"2014","journal-title":"J Card Fail"},{"key":"B36-20230816","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ejhf.17","article-title":"Why and when should we worry about worsening renal function?","volume":"16","author":"Damman","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"B37-20230816","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/eurheartj\/ehu320","article-title":"Terminology and definition of changes renal function in heart failure","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"key":"B38-20230816","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1093\/eurheartj\/ehr238","article-title":"Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial","volume":"32","author":"Blair","year":"2011","journal-title":"Eur Heart J"},{"key":"B39-20230816","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/eurjhf\/hfr123","article-title":"Influence of renal dysfunction phenotype on mortality in the setting of cardiac dysfunction: Analysis of three randomized controlled trials","volume":"13","author":"Testani","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"B40-20230816","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"key":"B41-20230816","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cardfail.2004.08.160","article-title":"Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: Observations from the IMPACT-HF registry","volume":"11","author":"O\u2019Connor","year":"2005","journal-title":"J Card Fail"},{"issue":"Suppl 1","key":"B42-20230816","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2006.09.011","article-title":"Congestion in acute heart failure syndromes: An essential target of evaluation and treatment","volume":"119","author":"Gheorghiade","year":"2006","journal-title":"Am J Med"},{"key":"B43-20230816","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.jacc.2012.08.957","article-title":"Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure","volume":"60","author":"Patarroyo","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B44-20230816","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ahj.2015.05.019","article-title":"Rationale and design of the Aquapheresis Versus Intravenous Diuretics and Hospitalization for Heart Failure (AVOID-HF) trial","volume":"170","author":"Costanzo","year":"2015","journal-title":"Am Heart J"},{"key":"B45-20230816","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijcard.2011.05.073","article-title":"Ultrafiltration for acute decompensated heart failure: Financial implications","volume":"154","author":"Kazory","year":"2012","journal-title":"Int J Cardiol"},{"key":"B46-20230816","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/CIRCOUTCOMES.109.853556","article-title":"Cost-consequences of ultrafiltration for acute heart failure: A decision model analysis","volume":"2","author":"Bradley","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"B47-20230816","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ahj.2008.09.019","article-title":"Ultrafiltration for heart failure: How fast should we move?","volume":"157","author":"Kazory","year":"2009","journal-title":"Am Heart J"},{"key":"B48-20230816","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11897-014-0209-5","article-title":"Understanding the relationship between readmission and quality of hospital care in heart failure","volume":"11","author":"Gilstrap","year":"2014","journal-title":"Curr Heart Fail Rep"},{"key":"B49-20230816","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"B50-20230816","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cjca.2012.10.007","article-title":"The 2012 Canadian Cardiovascular Society heart failure management guidelines update: Focus on acute and chronic heart failure","volume":"29","author":"McKelvie","year":"2013","journal-title":"Can J Cardiol"},{"key":"B51-20230816","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"B52-20230816","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2010.04.004","article-title":"HFSA 2010 Comprehensive Heart Failure Practice Guideline","volume":"16","author":"Lindenfeld","year":"2010","journal-title":"J Card Fail"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201608000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:46:14Z","timestamp":1786369574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201608000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.13461215","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,31]]}}}